0.53
price up icon7.72%   0.038
after-market アフターアワーズ: .54 0.01 +1.89%
loading
前日終値:
$0.492
開ける:
$0.49
24時間の取引高:
6.28M
Relative Volume:
0.95
時価総額:
$114.11M
収益:
$52.29M
当期純損益:
$-134.84M
株価収益率:
-0.7067
EPS:
-0.75
ネットキャッシュフロー:
$-117.11M
1週間 パフォーマンス:
+13.98%
1か月 パフォーマンス:
-13.40%
6か月 パフォーマンス:
-73.63%
1年 パフォーマンス:
-10.43%
1日の値動き範囲:
Value
$0.49
$0.5583
1週間の範囲:
Value
$0.4501
$0.5583
52週間の値動き範囲:
Value
$0.304
$3.179

Sangamo Therapeutics Inc Stock (SGMO) Company Profile

Name
名前
Sangamo Therapeutics Inc
Name
セクター
Healthcare (1170)
Name
電話
(510) 970-6000
Name
住所
501 CANAL BLVD., RICHMOND, CA
Name
職員
183
Name
Twitter
@sangamotx
Name
次回の収益日
2025-05-02
Name
最新のSEC提出書
Name
SGMO's Discussions on Twitter

SGMO を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
SGMO
Sangamo Therapeutics Inc
0.53 114.11M 52.29M -134.84M -117.11M -0.75
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
450.50 113.52B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
493.22 52.93B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
300.83 39.71B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
585.93 35.00B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
255.86 26.57B 3.81B -644.79M -669.77M -6.24

Sangamo Therapeutics Inc Stock (SGMO) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-13 アップグレード Truist Hold → Buy
2024-12-10 繰り返されました H.C. Wainwright Buy
2023-11-03 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2023-04-28 ダウングレード BofA Securities Neutral → Underperform
2023-02-27 アップグレード Wedbush Neutral → Outperform
2023-01-06 ダウングレード BofA Securities Buy → Neutral
2022-06-13 再開されました Wedbush Neutral
2021-05-04 開始されました RBC Capital Mkts Outperform
2021-01-07 再開されました Guggenheim Neutral
2021-01-06 開始されました Stifel Hold
2020-12-16 再開されました H.C. Wainwright Buy
2020-09-08 開始されました BofA Securities Buy
2020-07-07 開始されました SunTrust Buy
2019-08-26 開始されました H.C. Wainwright Buy
2018-11-14 ダウングレード JP Morgan Overweight → Neutral
2018-11-09 ダウングレード Guggenheim Buy → Neutral
2018-10-10 開始されました Guggenheim Buy
2018-06-20 開始されました BofA/Merrill Buy
2017-11-15 アップグレード Piper Jaffray Neutral → Overweight
2017-06-22 再開されました Jefferies Buy
2016-11-01 ダウングレード Wedbush Outperform → Neutral
2016-10-19 ダウングレード Piper Jaffray Overweight → Neutral
2015-12-04 開始されました Wells Fargo Outperform
2015-10-23 再開されました Jefferies Buy
2013-05-03 開始されました BioLogic Equity Research Sell
2011-02-23 繰り返されました JMP Securities Mkt Outperform
2010-07-29 繰り返されました Wedbush Outperform
2009-10-19 開始されました Brean Murray Sell
2009-10-07 繰り返されました Leerink Swann Outperform
2009-08-25 繰り返されました JMP Securities Mkt Outperform
すべてを表示

Sangamo Therapeutics Inc (SGMO) 最新ニュース

pulisher
Jun 03, 2025

H.C. Wainwright Maintains Buy Rating on Sangamo Therapeutics (SGMO) - MSN

Jun 03, 2025
pulisher
Jun 01, 2025

5 Best Stem Cell Companies to Invest In (June 2025) - Securities.io

Jun 01, 2025
pulisher
May 30, 2025

Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World

May 30, 2025
pulisher
May 29, 2025

Sangamo Therapeutics Announces Pricing of $23.0 Million Underwritten Offering - Zenopa

May 29, 2025
pulisher
May 27, 2025

Sangamo Therapeutics’ SWOT analysis: genomic medicine firm faces cash crunch - Investing.com

May 27, 2025
pulisher
May 26, 2025

Lazard Asset Management LLC Takes Position in Sangamo Therapeutics, Inc. (NASDAQ:SGMO) - Defense World

May 26, 2025
pulisher
May 24, 2025

Captrust Financial Advisors Makes New $30,000 Investment in Sangamo Therapeutics, Inc. (NASDAQ:SGMO) - Defense World

May 24, 2025
pulisher
May 22, 2025

StockNews.com Initiates Coverage on Sangamo Therapeutics (NASDAQ:SGMO) - Defense World

May 22, 2025
pulisher
May 16, 2025

Barclays Issues Pessimistic Forecast for Sangamo Therapeutics (NASDAQ:SGMO) Stock Price - Defense World

May 16, 2025
pulisher
May 15, 2025

Sangamo Biosciences’ Earnings Call: Progress Amid Challenges - TipRanks

May 15, 2025
pulisher
May 14, 2025

Sangamo Therapeutics (SGMO) Reports Q1 Loss, Misses Revenue Estimates - MSN

May 14, 2025
pulisher
May 14, 2025

Barclays Updates Price Target for Sangamo Therapeutics (SGMO) | SGMO Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Sangamo (SGMO) Price Target Reduced by Barclays | SGMO Stock New - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Sangamo Biosciences Announces $23 Million Share Offering - TipRanks

May 14, 2025
pulisher
May 14, 2025

Barclays Updates Price Target for Sangamo Therapeutics (SGMO) | - GuruFocus

May 14, 2025
pulisher
May 13, 2025

Sangamo Therapeutics (SGMO) Projects 2025 Operating Expenses Ami - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Sangamo Therapeutics Inc (SGMO) Q1 2025 Earnings Call Highlights: Strategic Partnerships and ... - Yahoo Finance

May 13, 2025
pulisher
May 13, 2025

Sangamo Therapeutics Inc (SGMO) Q1 2025 Earnings Call Highlights - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Sangamo Therapeutics prices $23M securities offering - MSN

May 13, 2025
pulisher
May 13, 2025

Market Setbacks: Major Stocks Face Financial Hurdles - Finimize

May 13, 2025
pulisher
May 13, 2025

Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2025 Earnings Call Transcript - Insider Monkey

May 13, 2025
pulisher
May 13, 2025

Sangamo Therapeutics (SGMO) Announces $23M Capital Raise - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Sangamo Therapeutics (SGMO) Reports First Quarter Revenue Below - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Sangamo Therapeutics (SGMO) Q1 Earnings Miss Expectations - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Sangamo Therapeutics Postpones First Quarter 2025 Conference Call to Later the Same Day - BioSpace

May 13, 2025
pulisher
May 13, 2025

Sangamo Therapeutics Reports Q1 2025 Progress and Financials - TipRanks

May 13, 2025
pulisher
May 12, 2025

Sangamo Therapeutics Q1 2025 Earnings Call Transcript - MarketBeat

May 12, 2025
pulisher
May 12, 2025

Transcript : Sangamo Therapeutics, Inc., Q1 2025 Earnings Call, May 12, 2025 - marketscreener.com

May 12, 2025
pulisher
May 12, 2025

Earnings call transcript: Sangamo Therapeutics faces stock drop after Q1 2025 call - Investing.com Nigeria

May 12, 2025
pulisher
May 12, 2025

Sangamo Therapeutics Reports Recent Business Highlights and Firs - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Sangamo Therapeutics (SGMO) Reports First Quarter Revenue Below Expectations | SGMO Stock News - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Sangamo Therapeutics Announces Pricing of $23.0 Million Underwri - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Sangamo Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 12, 2025
pulisher
May 12, 2025

Sangamo Therapeutics, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:SGMO) - Seeking Alpha

May 12, 2025
pulisher
May 12, 2025

Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2025 Financial Results | SGMO Stock News - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2025 Financial Results - BioSpace

May 12, 2025
pulisher
May 12, 2025

Sangamo: Q1 Earnings Snapshot - San Antonio Express-News

May 12, 2025
pulisher
May 12, 2025

Sangamo Therapeutics Announces First Quarter 2025 Earnings Call - Zenopa

May 12, 2025
pulisher
May 12, 2025

Sangamo Therapeutics (SGMO) Anticipates Q1 Earnings Release - GuruFocus

May 12, 2025
pulisher
May 08, 2025

Sangamo hits milestone toward accelerated approval for ST-920 - Fabry Disease News

May 08, 2025
pulisher
May 07, 2025

Sangamo Therapeutics Announces Important Derisking Milestones in Pathway to Anticipated BLA Submission for ST-920 in Fabry Disease - BioSpace

May 07, 2025
pulisher
May 06, 2025

Sangamo Biosciences Receives Nasdaq Deficiency Notice - TipRanks

May 06, 2025

Sangamo Therapeutics Inc (SGMO) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$73.62
price up icon 1.21%
$22.20
price up icon 1.79%
$20.59
price up icon 4.36%
$33.78
price up icon 0.09%
$108.49
price down icon 1.51%
biotechnology ONC
$255.86
price down icon 0.44%
大文字化:     |  ボリューム (24 時間):